Categories Earnings, Technology

Universal Display’s stock surges nearly 9% on Q2 earnings beat

Universal Display (OLED) reported its second quarter results today after the bell. The company’s shares surged nearly 9% in the extended period of trading due to solid earnings which topped analysts’ estimates.

Revenue plunged 45% in the quarter to $56.1 million due to weaker demand for OLED panels and change in accounting standards. Last year, the company received $45 million as license revenue from Samsung Display which also impacted recently concluded second quarter revenues.

It’s worth noting that Samsung Display (SDC), which accounted for 62% of Universal’s revenues in 2017, is a key customer along with LG Display. Any impact in demand for its OLED products from Samsung will have a ripple effect on Universal’s top and bottom line.

Adjusted earnings came in at $0.31 per share beating street consensus. The company’s board has declared a dividend of $0.06 per share compared to $0.03 per share declared last year.

Related: Universal Display Q1 2018 Transcript

Material sales business, which brings in lion’s share of revenues, saw 21% decrease in revenues due to softer demand for OLED panels from premium smartphone makers due to weak demand for high-end phones in the market. License revenues dropped 71% to $15.5 million due to the reduction in royalty revenues for licensed products from customers and change in accounting standards.

The OLED display maker has retained its outlook for 2018. Revenue is expected to come in the range of $280 million to $310 million due to softer demand for its products from the key customers. The company saw its stock price fell nearly 42% in 2018 and about 13% in the last 12 months.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top